$The effects of monoclonal anti‐CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia$

The effects of monoclonal anti‐CD47 on RBCs, compatibility testing, and transfusion requirements in refractory acute myeloid leukemia

<p><strong>BACKGROUND</strong></p> <p>CD47 is a novel therapeutic target in the treatment of solid‐organ and hematologic malignancies. CD47 is also expressed on RBCs. Here, we report our experience of the RBC effects and the impact on blood bank testing and transfusion...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Brierley, CK, Staves, J, Roberts, C, Johnson, H, Vyas, P, Goodnough, LT, Murphy, MF
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Wiley 2019

Gelijkaardige items

Mitigating of the interference of anti-CD47 monoclonal antibody on transfusion compatibility detection
door: Yiyang LYU, et al.
Gepubliceerd in: (2023-03-01)

Concepts of blood transfusion in adults.
door: Goodnough, LT, et al.
Gepubliceerd in: (2013)

Do liberal blood transfusions cause more harm than good?
door: Goodnough, LT, et al.
Gepubliceerd in: (2014)

Anti-CD47 monoclonal antibody interferes with compatibility test for blood transfusion:a case report
door: Liuxin TAN, et al.
Gepubliceerd in: (2023-01-01)

Efficacy analysis of transfusion of suspended RBCs and washed RBCs in patients with positive direct Coombs testing results
door: Wenjun QUE, et al.
Gepubliceerd in: (2022-04-01)

Status survey of uncrossmatched type O suspended RBCs in patients with emergency transfusion
door: PENG Zhuoyue, et al.
Gepubliceerd in: (2025-01-01)

How do transfusion services manage patients taking therapies such as anti‐ CD38 and anti‐ CD47 known to interfere with red blood cell compatibility testing?
door: Murphy, MF, et al.
Gepubliceerd in: (2024)

Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model
door: Sean R. Stowell, et al.
Gepubliceerd in: (2015-10-01)

Molecular cloning of RBCS genes in Selaginella and the evolution of the rbcS gene family
door: Wang Bo, et al.
Gepubliceerd in: (2015-01-01)

Commentary: Blood transfusion strategies in elderly patients
door: Murphy, M, et al.
Gepubliceerd in: (2017)

Changing indications for red cell transfusion.
door: Ballard, S, et al.
Gepubliceerd in: (2007)

Construction and Validation of an Assistant Decision-Making Model for Platelet Transfusion Refractoriness in Patients with Acute Myeloid Leukemia
door: Ruixue Ma BA, et al.
Gepubliceerd in: (2024-10-01)

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia
door: Xuelian Hu, et al.
Gepubliceerd in: (2020-07-01)

Red cell transfusion in haematology: can we reduce usage further?
door: Gooding, S, et al.
Gepubliceerd in: (2009)

Effects of introduction of sorghum RbcS with rice RbcS knockdown by RNAi on photosynthetic activity and dry weight in rice
door: Kazuma Sakoda, et al.
Gepubliceerd in: (2021-07-01)

Patient safety and blood transfusion: new solutions.
door: Dzik, W, et al.
Gepubliceerd in: (2003)

Treatment for Relapsed/Refractory Acute Myeloid Leukemia
door: Felicitas Thol, et al.
Gepubliceerd in: (2021-06-01)

CD47 expression in acute myeloid leukemia varies according to genotype
door: Andrea Marra, et al.
Gepubliceerd in: (2023-06-01)

Acute myeloid leukemia in a patient with constitutional 47,XXY karyotype
door: Marla M. Jalbut, et al.
Gepubliceerd in: (2015-01-01)

TLR3 agonism augments CD47 inhibition in acute myeloid leukemia
door: Haley E. Ramsey, et al.
Gepubliceerd in: (2023-12-01)

Treatment of pediatric relapsed and refractory acute myeloid leukemia
door: F. A. Makhacheva, et al.
Gepubliceerd in: (2023-05-01)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
door: Radhakrishnan Ramchandren, et al.
Gepubliceerd in: (2009-05-01)

Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
door: James L Gulley, et al.
Gepubliceerd in: (2022-01-01)

Microscopic images dataset for automation of RBCs counting
door: Sherif Abbas
Gepubliceerd in: (2015-12-01)

Sticky collisions of ultracold RbCs molecules
door: Philip D. Gregory, et al.
Gepubliceerd in: (2019-07-01)

Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
door: Stein, EM, et al.
Gepubliceerd in: (2017)

Myeloid pre-leukemia and leukemia of Down syndrome
door: Cruz Hernandez, D, et al.
Gepubliceerd in: (2020)

The impact of electronic decision support and electronic remote blood issue on transfusion practice
door: Hibbs, S, et al.
Gepubliceerd in: (2014)

The impact of electronic decision support and electronic remote blood issue on transfusion practice.
door: Hibbs, S, et al.
Gepubliceerd in: (2014)

Anesthesiologic management of cesarean section at 35-weeks pregnancy with acute myeloid leukemia and profound thrombocytopenia refractory to platelet transfusion: A case report
door: Jemea Bonaventure, et al.
Gepubliceerd in: (2020-01-01)

The risks of red cell transfusion for hip fracture surgery in the elderly.
door: Shokoohi, A, et al.
Gepubliceerd in: (2012)

How do we monitor hospital transfusion practice using an end-to-end electronic transfusion management system?
door: Murphy, M, et al.
Gepubliceerd in: (2012)

How do we monitor hospital transfusion practice using an end-to-end electronic transfusion management system?
door: Murphy, M, et al.
Gepubliceerd in: (2012)

Platelet Transfusion Refractoriness
door: Anna Mira Lubis MD, et al.
Gepubliceerd in: (2024-09-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
door: E. G. Ovsyannikova, et al.
Gepubliceerd in: (2014-07-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
door: E. G. Ovsyannikova, et al.
Gepubliceerd in: (2014-07-01)

O & M of trickling filters, RBCs, and related processes /
Gepubliceerd in: (f)

Analysis and prospect of platelet compatible transfusion
door: Faming ZHU, et al.
Gepubliceerd in: (2022-11-01)

Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine
door: Mathilde Gavillet, et al.
Gepubliceerd in: (2012-12-01)

Removing the interference of daratumumab on transfusion compatibility testing and transfusion efficacy comparison
door: Jingdan ZHANG, et al.
Gepubliceerd in: (2024-02-01)